Clinical trial
A Clinical Research on SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration
NCT06589271 is registered in ClinicalTrials.gov with Sclnow Biotechnology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Research on SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration
- Lead sponsor
- Sclnow Biotechnology Co., Ltd.
- Phase
- Phase 1
- Overall status
- Suspended
- Start date
- December 31, 2026
- Completion date
- December 31, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lumbar disc degeneration